High dose chemo & stem cell transplantation results in long-term survival for … – EurekAlert (press release)
|
High dose chemo & stem cell transplantation results in long-term survival for …
EurekAlert (press release) (Boston)–Patients with Light-chain (AL) amyloidosis who are treated with high-dose chemotherapy (melphalan) and autologous (one's own) stem cell transplantation (HDM/SCT) have the greatest success for long-term survival. These findings, which appear … |
